In this study, we assessed intact and total FGF-21 levels in two cohorts of subjects with putative risk for MetS and obesity-related diseases with the goal of identifying the relationships between FGF-21 serum level and visceral obesity and its related complications. The gene discussed is FGF21; the disease is obesity disorder.